Breast Cancer | Beyond the Guidelines: Clinical Investigator Perspectives on the Management of Triple-Negative Breast Cancer

published 1 month ago by Dr Neil Love

Featuring perspectives from Drs P Kelly Marcom, Joyce O’Shaughnessy and Hope S Rugo and Professor Peter Schmid, including the following topics: Introduction (0:00) Optimal Integration of Immune Checkpoint Inhibitors into the Management of Metastatic Triple-Negative Breast Cancer (mTNBC) — Professor Peter Schmid, MD, PhD (2:00) Novel Applications of Immune Checkpoint Inhibitors for Patients with Early TNBC — Hope S Rugo, MD (34:59) Current and Future Role of PARP Inhibitors for Patients with TNBC and a BRCA Mutation — P Kelly Marcom, MD (45:40) Current and Future Management of PD-L1-Negative mTNBC — Joyce O’Shaughnessy, MD (1:11:19) CME information and select publications

more episodes from Research To Practice | Oncology Videos